JP2004502446A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004502446A5 JP2004502446A5 JP2002509358A JP2002509358A JP2004502446A5 JP 2004502446 A5 JP2004502446 A5 JP 2004502446A5 JP 2002509358 A JP2002509358 A JP 2002509358A JP 2002509358 A JP2002509358 A JP 2002509358A JP 2004502446 A5 JP2004502446 A5 JP 2004502446A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- polynucleotide
- seq
- amino acid
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 description 16
- 102000004196 processed proteins & peptides Human genes 0.000 description 16
- 108090000765 processed proteins & peptides Proteins 0.000 description 16
- 239000002157 polynucleotide Substances 0.000 description 12
- 102000040430 polynucleotide Human genes 0.000 description 11
- 108091033319 polynucleotide Proteins 0.000 description 11
- 229960005486 vaccine Drugs 0.000 description 6
- 125000003275 alpha amino acid group Chemical group 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- -1 amino Chemical group 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 238000011321 prophylaxis Methods 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000031729 Bacteremia Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010016228 Fasciitis Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21646500P | 2000-07-06 | 2000-07-06 | |
| US60/216,465 | 2000-07-06 | ||
| PCT/CA2001/001001 WO2002004495A2 (en) | 2000-07-06 | 2001-07-06 | Streptococcus pyogenes antigen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004502446A JP2004502446A (ja) | 2004-01-29 |
| JP2004502446A5 true JP2004502446A5 (enExample) | 2008-09-04 |
| JP4718099B2 JP4718099B2 (ja) | 2011-07-06 |
Family
ID=22807177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002509358A Expired - Fee Related JP4718099B2 (ja) | 2000-07-06 | 2001-07-06 | ストレプトコッカス・パイオジェンス抗原 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7247308B2 (enExample) |
| EP (1) | EP1297145B1 (enExample) |
| JP (1) | JP4718099B2 (enExample) |
| AT (1) | ATE412750T1 (enExample) |
| AU (1) | AU7227001A (enExample) |
| BR (1) | BR0112497A (enExample) |
| CA (1) | CA2413576C (enExample) |
| DE (1) | DE60136360D1 (enExample) |
| ES (1) | ES2316458T3 (enExample) |
| WO (1) | WO2002004495A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4718099B2 (ja) | 2000-07-06 | 2011-07-06 | アイディー バイオメディカル コーポレイション | ストレプトコッカス・パイオジェンス抗原 |
| CA2881568C (en) | 2000-10-27 | 2019-09-24 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from streptococcus groups a & b |
| AU2002216863B8 (en) * | 2000-12-21 | 2008-03-20 | Id Biomedical Corporation | Streptococcus pyogenes antigens and corresponding DNA fragments |
| US20070053924A1 (en) * | 2002-08-26 | 2007-03-08 | Herve Tettelin | Conserved and specific streptococcal genomes |
| ES2505695T3 (es) | 2003-07-31 | 2014-10-10 | Novartis Vaccines And Diagnostics, Inc. | Composiciones inmunógenas para Streptococcus pyogenes |
| WO2005017093A2 (en) * | 2003-08-15 | 2005-02-24 | Id Biomedical Corporation | Polypeptides of streptococcus pyogenes |
| US8945589B2 (en) * | 2003-09-15 | 2015-02-03 | Novartis Vaccines And Diagnostics, Srl | Immunogenic compositions for Streptococcus agalactiae |
| JP2008508320A (ja) | 2004-07-29 | 2008-03-21 | カイロン コーポレイション | Ｓｔｒｅｐｔｏｃｏｃｃｕｓａｇａｌａｃｔｉａｅのようなグラム陽性細菌に対する免疫原性組成物 |
| US7838010B2 (en) * | 2004-10-08 | 2010-11-23 | Novartis Vaccines And Diagnostics S.R.L. | Immunogenic and therapeutic compositions for Streptococcus pyogenes |
| GB2428006A (en) * | 2005-07-07 | 2007-01-17 | Jevgenis Morov | AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria |
| PT2054431E (pt) * | 2006-06-09 | 2011-11-03 | Novartis Ag | Confórmeros de adesinas bacterianas |
| CA2668018A1 (en) * | 2006-10-30 | 2008-09-12 | Novartis Ag | Immunogenic and therapeutic compositions for streptococcus pyogenes |
| KR101621837B1 (ko) | 2007-09-12 | 2016-05-17 | 노파르티스 아게 | Ｇａｓ57 돌연변이 항원 및 ｇａｓ57 항체 |
| EP2537857B1 (en) | 2007-12-21 | 2017-01-18 | GlaxoSmithKline Biologicals SA | Mutant forms of streptolysin O |
| AU2012271336B2 (en) | 2011-06-17 | 2017-03-02 | University Of Tennessee Research Foundation | Group A streptococcus multivalent vaccine |
| WO2014124446A1 (en) | 2013-02-11 | 2014-08-14 | University Of Tennessee Research Foundation | Group a streptococcal m-related proteins and methods of use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0916726A1 (en) * | 1997-11-13 | 1999-05-19 | Rijksuniversiteit te Groningen | Attaching substances to micro-organisms |
| JP4718099B2 (ja) | 2000-07-06 | 2011-07-06 | アイディー バイオメディカル コーポレイション | ストレプトコッカス・パイオジェンス抗原 |
-
2001
- 2001-07-06 JP JP2002509358A patent/JP4718099B2/ja not_active Expired - Fee Related
- 2001-07-06 AT AT01951286T patent/ATE412750T1/de not_active IP Right Cessation
- 2001-07-06 ES ES01951286T patent/ES2316458T3/es not_active Expired - Lifetime
- 2001-07-06 CA CA2413576A patent/CA2413576C/en not_active Expired - Fee Related
- 2001-07-06 WO PCT/CA2001/001001 patent/WO2002004495A2/en not_active Ceased
- 2001-07-06 AU AU7227001A patent/AU7227001A/xx active Pending
- 2001-07-06 US US10/332,231 patent/US7247308B2/en not_active Expired - Lifetime
- 2001-07-06 DE DE60136360T patent/DE60136360D1/de not_active Expired - Lifetime
- 2001-07-06 EP EP01951286A patent/EP1297145B1/en not_active Expired - Lifetime
- 2001-07-06 BR BR0112497-8A patent/BR0112497A/pt not_active IP Right Cessation
-
2007
- 2007-07-09 US US11/775,131 patent/US7811585B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004502446A5 (enExample) | ||
| US8313928B2 (en) | Expression system | |
| JP2002510494A5 (enExample) | ||
| JP2002537791A5 (enExample) | ||
| JP2007502101A5 (enExample) | ||
| CA2395499A1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| JP2004501618A5 (enExample) | ||
| CA2385325A1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| CA2356836A1 (en) | Novel streptococcus antigens | |
| RU2677799C2 (ru) | Модифицированные суперспиральные белки с улучшенными свойствами | |
| JP2002542827A5 (enExample) | ||
| ATE482714T1 (de) | Modifizierter hitzeschockprotein-antigenpeptid- komplex | |
| CA2413576A1 (en) | Streptococcus pyogenes antigens | |
| JP2002542169A5 (enExample) | ||
| CN107737334B (zh) | 一种预防a型链球菌感染的广谱多联亚单位疫苗 | |
| US5352588A (en) | Streptococcal immunoglobulin a binding protein encoded by emmL2.2 | |
| CN104415329B (zh) | 一种抑制链球菌和/或预防链球菌感染的疫苗 | |
| AU743165B2 (en) | Live attenuated bacteria of the species Actinobacillus pleuropneumoniae | |
| JP2005512518A5 (enExample) | ||
| JP2002516662A5 (enExample) | ||
| WO2001046226A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| JP2004531235A5 (enExample) | ||
| JP2004529601A5 (enExample) | ||
| CA2438921A1 (en) | Streptococcus pyogenes polypeptides and corresponding dna fragments | |
| CN108671227A (zh) | 一种预防猪链球菌感染的广谱多联亚单位疫苗 |